Riskpilot← Back to searchSign inGet full accessPharma Beauty Sweden AB
ABActiveOrg 5592236615Vikingagatan 20Beauty care and other beauty treatment activities · NACE 9622Est. 20190 employees
Revenue 2024
SEK 37K
-90% vs 2023
EBITDA margin
-206.1%
+39% vs 2023
Equity ratio
10.4%
Financial strength
Net profit 2024
SEK -132K
+21% vs 2023
| Revenue | SEK 37K | -90% |
| EBITDA | SEK -76K | +39% |
| Net profit | SEK -132K | +21% |
| Total assets | SEK 662K | +3% |
| Equity | SEK 69K | +35% |
| Employees | 0 | — |
Legal name
Pharma Beauty Sweden AB
Org number
5592236615
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
23 oktober 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva klinik och skönhetsverksamhet samt tillhandahålla konsulttjänster relaterade till hälsa, vård och skönhet.
Address
Vikingagatan 20
Email
info@smashingbeauty.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 4 | 359 | 37 |
| Staff expenses | — | — | — | −15 | −0 |
| EBITDA | −2 | −47 | −4 | −123 | −76 |
| Depreciation & amort. | −0 | −0 | — | −45 | −55 |
| EBIT | −2 | −47 | −4 | −168 | −131 |
| Net financials | — | — | 0 | 0 | −2 |
| Profit before tax | −2 | −47 | −4 | −168 | −132 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −2 | −47 | −4 | −168 | −132 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 50 | 60 | 48 | 644 | 662 |
| Equity | 48 | 51 | 47 | 51 | 69 |
| Long-term debt | 0 | 0 | — | 540 | 457 |
| Short-term debt | 2 | 9 | 1 | 53 | 137 |
| Total debt | 2 | 9 | 1 | 593 | 593 |
EBITDA margin
-206.1%
This company
15.8%
Market median
-1404% vs market
20202024
Equity ratio
10.4%
This company
38.2%
Market median
-73% vs market
20202024
Return on equity
-192.5%
This company
18.4%
Market median
-1146% vs market
20202024
Net profit margin
-360.5%
This company
8.1%
Market median
-4551% vs market
20202024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20202024
Debt / equity
8.64×
This company
0.62×
Market median
-1294% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2020 | |
| Former (2) | ||
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
RM Consulting & Invest AB
Pharma Beauty Sweden AB Board members of Pharma Beauty Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sylwia Chaliss Monica von Der Osten-Sacken | Deputy Board Member | 0 companies |
| Claudia Mamoka | Deputy Board Member | 0 companies |
| Rudolf Mamoka | Board of Directors | 0 companies |
| Macy Marjan Furukrantz | Deputy Board Member | 0 companies |